NCT00517062View on ClinicalTrials.gov

Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Growth Hormone Deficiency
Interventions
DRUG

Growth hormone (Genotropin)

Growth hormone 0.1 mg self-injected once a day subcutaneously at bedtime.

DRUG

Placebo

Placebo self-injected once a day subcutaneously at bedtime.

Trial Locations (1)

97239

Oregon Health and Science University, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT00517062 - Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates | Biotech Hunter | Biotech Hunter